Lantus (insulin glargine [rDNA origin] injection)

DRUG2 trials

Sponsors

Sanofi

Conditions

Diabetes Mellitus

Phase 3

Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment

CompletedNCT00046462

SanofiDiabetes Mellitus

Start: 2001-11-30End: 2004-12-31Target: 240Updated: 2011-01-11

Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents

CompletedNCT00046501

SanofiDiabetes Mellitus

Start: 2002-11-30Target: 250Updated: 2011-01-11